Thomas Swan Appoints Ray Fahmy as President of SCI

Thomas Swan has appointed Ray Fahmy as president of its US subsidiary Swan...
Thomas Swan has appointed Ray Fahmy as president of its US subsidiary Swan Chemical Inc. (SCI). Source: Thomas Swan

UK-based performance and specialty chemical manufacturer Thomas Swan has appointed Ray Fahmy as president of its US subsidiary Swan Chemical Inc. (SCI). He joined SCI in April 2019, taking over from Chuck Van Fleet who retired after 22 years with the company.

Fahmy has more than 30 years of experience in the specialty chemical industry and in particular within the biocide and preservatives market. Prior to joining SCI, he headed Lonza’s global hygiene and preservation business.

Harry Swan, CEO of Thomas Swan said: “Ray is a key appointment for us as we look to grow SCI over the coming years. The North and South American markets are a strategic growth area for Thomas Swan through additional sales of our UK manufactured products, wider distribution of other companies’ products and the establishment of our Contract Manufacturing services in the USA.”

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read